Hair loss and prostate cancer [CNN: 5-18-2011]
- January 19th, 2012
- Write comment
Subscribe for daily health news. Like/Dislike, Favorite, Comment, Embed on Blog, Facebook Share, and Tweet this video. Get the word out on this video. – Wednesday May 18 2011 7:10 am en. wikipedia. org Finasteride (marketed by Merck under the trademark names Proscar and Propecia, also available under several generic names) is a synthetic antiandrogen that inhibits type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Finasteride was initially approved by the US Food and Drug Administration (FDA) in 1992 under the brand name Proscar, as treatment for benign prostatic hyperplasia (BPH). In 1997, the FDA approved finasteride to treat male pattern baldness (MPB) under the brand name Propecia. Finasteride is used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). Finasteride is used for the treatment of benign prostatic hyperplasia (BPH) (also known as enlarged prostate) at a dose of 5 mg once a day. It may take six months or more to see the full effects of finasteride. If the drug is discontinued, any therapeutic benefits will be reversed. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow. In a 5-year study of men with mild to moderate hair loss, 2 out of 3 of the men who took 1 mg of finasteride daily regrew some hair, as measured by hair counts. In contrast . . .